Devices › Device types
FDA product code LCJ · class U · Unknown
Tissue expander and accessories: medical device reports filed with FDA
5,173 reports carry this product code, 1993–2026; 15 brands with a page.
- 5,173
- reports with this product code
- 0% of all MAUDE reports
- 447
- reports, 12 months to August 2026
- 467 in the 12 months before
- 15.5%
- classified as malfunction
- 62.3% across all reports
- 0.1%
- classified as death, as reported
- 0.9% across all reports
Product code LCJ is FDA's classification for "Tissue expander and accessories" (unknown panel), a class U device. 5,173 medical device reports carry this product code, 0% of the MAUDE database, from July 1993 to August 2026.
447 reports arrived in the 12 months to August 2026, close to the 467 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (82.4%), malfunction (15.5%) and other (1%). 15 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| Unk Tissue Expander | 481 | 63 | 0% | 3.1% |
| MENTOR CPX 4 Breast Tissue Expander with Suture Tabs | 319 | 37 | 0% | 15% |
| Unknown Tissue Expanders | 315 | 24 | 0% | 6.6% |
| ARTOURA Breast Tissue Expander | 313 | 8 | 0% | 9.9% |
| MENTOR Tissue Expander | 215 | 15 | 0% | 25.1% |
| Mentor Cpx 4 Breast Tissue Expander | 182 | 4 | 0% | 13.2% |
| Mcghan | 39 | 0 | 0% | 26.7% |
| Mentor | 31 | 0 | 0.1% | 30.1% |
| Motiva Implants | 29 | 1,729 | 0% | 4.6% |
| Breast Implant | 3 | 97 | 1.3% | 11.4% |
| Non Mentor Product | 3 | 22 | 0% | 0.5% |
| MENTOR MemoryGel Breast Implant | 2 | 7,708 | 0% | 1.7% |
| Unknown Gel Implants | 2 | 703 | 0% | 0.2% |
| Saline Breast Implant | 1 | 0 | 1.1% | 10.2% |
| Unknown Mentor Implant | 1 | 16 | 0% | 0% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Mentor Texas | 2,352 | 45.5% |
| Allergan Costa Rica | 1,780 | 34.4% |
| Mentor | 159 | 3.1% |
| Allergan | 113 | 2.2% |
| Mcghan Medical | 104 | 2% |
| Sientra | 87 | 1.7% |
| Establishment Labs | 72 | 1.4% |
| Mentor Worldwide | 43 | 0.8% |
| B Braun Medical | 25 | 0.5% |
| Medical Engineering | 11 | 0.2% |
| Allergan Irvine | 10 | 0.2% |
| Tiger Aesthetics Medical | 9 | 0.2% |
| Dow Corning | 4 | 0.1% |
| Lifecell | 2 | 0% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Material rupture | 1,827 | 35.3% |
| Fluid/blood leak | 802 | 15.5% |
| Explanted | 217 | 4.2% |
| Breakthe device broke | 157 | 3% |
| Device appears to trigger rejection | 144 | 2.8% |
| Leak/splashthe device leaked | 112 | 2.2% |
| Off-label use | 104 | 2% |
| Deflation, cause unknown | 94 | 1.8% |
| Patient-device incompatibilitythe device did not suit the patient | 90 | 1.7% |
| Deflation problem | 82 | 1.6% |
| Improper or incorrect procedure or method | 68 | 1.3% |
| Inflation problem | 63 | 1.2% |
| Insufficient device problem information | 63 | 1.2% |
| Replace | 61 | 1.2% |
| Implant, removal of | 55 | 1.1% |
| Defective devicethe device was defective | 52 | 1% |
| Migrationthe device moved from where it was placed | 50 | 1% |
| Device contamination with chemical or other material | 45 | 0.9% |
| Device handling problem | 33 | 0.6% |
| Connection problema connection problem | 31 | 0.6% |
Questions about tissue expander and accessories reports
What is product code LCJ?
FDA's classification code for "Tissue expander and accessories", class U, reviewed by the unknown panel. Every device report carries the product code of the device involved.
How many reports carry this code?
5,173 reports through August 2026, 447 of them in the latest 12 months.
Which brands appear most often?
Unk Tissue Expander (481), MENTOR CPX 4 Breast Tissue Expander with Suture Tabs (319), Unknown Tissue Expanders (315), ARTOURA Breast Tissue Expander (313) and MENTOR Tissue Expander (215). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.